Company intelligence / Profile preview

La Merie

Alcobendas, Madrid, Spain

Ownership: Private
Development stage: Other

Overview

La Merie is a specialized business intelligence and consultancy firm focused on the global biotechnology and pharmaceutical industries. The company provides detailed R&D reports, pipeline databases, and strategic analysis covering various therapeutic areas, including oncology, immunology, and rare diseases. La Merie's services are designed to support business development, licensing, and investment decisions for industry professionals. They are particularly recognized for their Competitor Analysis and Market Analysis reports that track the development of biologics, biosimilars, and novel small molecules. Additionally, the company operates the news platform PipelineReview.com, which provides real-time updates on clinical trials and industry transactions.

Industry: Consulting

Beyond the preview

Go deeper on La Merie.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on La Merie.

Explore the full profile